Agnuside

CAS: 11027-63-7

Ref. 3D-MA08289

Product Information

• Name: Agnuside
• Synonyms: (-)-Buddlejoside A, (1S,4aR,5S,7aS)-1,4a,5,7a-Tetrahydro-5-hydroxy-7-[[(4-hydroxybenzoyl)oxy]methyl]cyclopenta[c]pyran-1-yl β-<span class="text-smallcaps">D</span>-glucopyranoside, Agnoside, Agnuside WITH HPLC, Agnuside(P), Chasteberry Oil, [(1R,2S,6S,7S)-7-Hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-oxabicyclo[4.3.0]nona-4,8-dien-9-yl]methyl 4-hydroxybenzoate, [(1S,4aR,5S,7aS)-1-(beta-D-glucopyranosyloxy)-5-hydroxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-7-yl]methyl 4-hydroxybenzoate, β-<span class="text-smallcaps">D</span>-Glucopyranoside, (1S,4aR,5S,7aS)-1,4a,5,7a-tetrahydro-5-hydroxy-7-[[(4-hydroxybenzoyl)oxy]methyl]cyclopenta[c]pyran-1-yl, β-<span class="text-smallcaps">D</span>-Glucopyranoside, 1,4a,5,7a-tetrahydro-5-hydroxy-7-[[(4-hydroxybenzoyl)oxy]methyl]cyclopenta[c]pyran-1-yl, (1α,4aα,5α,7aα)-
• CAS: 11027-63-7

Description

Agnuside is a natural compound that inhibits the activity of p-hydroxybenzoic acid. Agnuside has been shown to have significant cytotoxicity against tumor cells, with a matrix effect that may be due to its ability to alter intracellular Ca2+ levels. It also has drug interactions with drugs such as phenobarbital and theophylline, which can lead to increased toxicity. Agnuside has been shown in a molecular docking analysis to bind to the active site of target enzymes such as P450scc and 3β-hydroxysteroid dehydrogenase type 1 (3β-HSD). The compound is then converted by preparative high-performance liquid chromatography (prep HPLC) into its corresponding aglycone, p-hydroxybenzoic acid, which can be used for analytical purposes.

• Brand: Biosynth

Chemical properties

• Molecular weight: 466.44 g/mol
• Formula: C₂₂H₂₆O₁₁
• Purity: Min. 95 Area-%
• Color/Form: Brown Powder